GA
GILD icon

Glenhill Advisors’s Gilead Sciences GILD Stock Holding History

Glenhill Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,154
Closed -$261K – 62
2014
Q2 		$261K Sell
3,154
-2,569
-45% -$200K 0.02% 77
2014
Q1 		$405K Buy
5,723
+2,334
+69% +$183K 0.04% 89
2013
Q4 		$254K Buy
+3,389
New +$236K 0.02% 80

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glenhill Advisors's GILD Position: Q3 2014 in Review

Glenhill Advisors sold out of Gilead Sciences (GILD) in Q3 2014, closing a stake of 3,154 shares — an estimated $261K sold.

Glenhill Advisors first reported a position in GILD in Q4 2013 and held it in 3 quarters. The position peaked at $405K in Q1 2014. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • Glenhill Advisors reported no remaining Gilead Sciences position as of Q3 2014 after selling out during the quarter.
  • Glenhill Advisors sold 3,154 Gilead Sciences shares in Q3 2014, an estimated $261K.
  • Glenhill Advisors first reported a position in Gilead Sciences in Q4 2013 and held it in 3 quarters.
  • Glenhill Advisors's Gilead Sciences position peaked at $405K in Q1 2014.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on Glenhill Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.